IP Library › Granted Patent US 7,098,024
Granted Patent B2
US 7,098,024 · App. 10/684,656 · Granted Aug 29, 2006

Depsipeptide compound

Assignee: Astellas Pharma Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,098,024
App. No.
10/684,656
Granted
Aug 29, 2006
Kind
B2
Abstract

This invention relates to a novel compound which has a cytotoxic activity and TGF-β like activity for human cancer cells and is useful as an antitumor agent and to a pharmaceutical composition which contains the same.

Claims (1)

1. A biologically pure culture of Pseudomonas strain Q71576 (FERM BP-6944).

Assignments (1)
MERGER Recorded Sep 22, 2005
From: YAMANOUCHI PHARMACEUTICAL CO., LTD.
To: ASTELLAS PHARMA INC.
Reel/Frame 016570/0324 →
Priority Claims (1)
JP P.11-7040 · Jan 13, 1999 · national
Continuity (2)
Continuation 0988930300
Related Publication 20040082054A1 · Apr 29, 2004